| 2007 | | 5-fluorouracil, mitomycin-C, and polysaccharide-K adjuvant chemoimmunotherapy for locally advanced gastric cancer: the prognostic significance of frequent perineural invasion | 김명욱, 김영배, 김효철, 박준성, 조용관, 주희재, 최진혁, 한상욱 |
| 2013 | | 5-Fluorouracil, mitomycin-c, and polysaccharide-k versus uracil-ftorafur and polysaccharide-K as adjuvant chemoimmunotherapy for patients with locally advanced gastric cancer with curative resection. | 강석윤, 박준성, 안미선, 이광재, 이순영, 이현우, 정성현, 조용관, 최진혁, 한상욱 |
| 2016 | | A Korean Nationwide Survey for Breakthrough Cancer Pain in an Inpatient Setting | 강석윤 |
| 2019 | | A Machine-Learning Approach Using PET-Based Radiomics to Predict the Histological Subtypes of Lung Cancer | 고영화, 안미선, 이수진 |
| 2020 | | A membrane-tethering pepducin derived from formyl peptide receptor 3 shows strong therapeutic effects against sepsis | 박준성 |
| 2016 | | A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806) | 강석윤, 최진혁 |
| 1996 | | A multicentre comparison of once-daily subcutaneous dalteparin (low molecular weight heparin) and continuous intravenous heparin in the treatment of deep vein thrombosis. | 김효철 |
| 2011 | | A novel algorithm for detection of adverse drug reaction signals using a hospital electronic medical record database | 감혜진, 강석윤, 박래웅, 박인휘, 이기영 |
| 2014 | | A novel delivery platform for therapeutic peptides. | 박준성 |
| 2024 | | A Phase II Trial of Nintedanib in Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma: In-Depth Analysis of Nintedanib Arm from the KCSG HN 15-16 TRIUMPH Trial | 이현우 |
| 2016 | | A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis | 정성현 |
| 2015 | | A prospective, multicenter, observational study of long-term decitabine treatment in patients with myelodysplastic syndrome. | 정성현 |
| 2017 | | A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma | 박준성, 정성현 |
| 2021 | | A randomised phase 2b study comparing the efficacy and safety of belotecan vs. topotecan as monotherapy for sensitive-relapsed small-cell lung cancer | 최진혁 |
| 2013 | | A randomized, multi-center, open-label, phase II study of once-per-cycle DA-3031, a biosimilar pegylated G-CSF, compared with daily filgrastim in patients receiving TAC chemotherapy for early-stage breast cancer. | 강석윤 |
| 2017 | | A randomized, multi-center, open-label, phase III study of once-per-cycle DA-3031, a pegylated G-CSF, in comparison with daily filgrastim in patients receiving TAC chemotherapy for breast cancer | 강석윤 |
| 2015 | | A rare case of chronic myelogenous leukemia and plasma cell myeloma in the same patient. | 박준성, 조성란, 한재호 |
| 2019 | | Abrogation of B-Raf(V600E) induced senescence by FoxM1 expression | 강석윤, 김장희, 박태준, 최용원 |
| 2011 | | Acquisition of a BCR-ABL1 transcript in a patient with disease progression from MDS with fibrosis to AML with myelodysplasia-related changes. | 김현주, 김효철, 박준성, 이현우, 정성현, 조성란 |
| 2011 | | Activation of CXCR2 by extracellular matrix degradation product acetylated Pro-Gly-Pro has therapeutic effects against sepsis. | 박준성 |
| 2010 | | Activation of human monocytes by a formyl peptide receptor 2-derived pepducin. | 박준성 |
| 1994 | | Acute promyelocytic leukemia in pregnancy: all-trans retinoic acid as a newer therapeutic option. | 김효철 |
| 2021 | | Adaptive natural killer cells facilitate effector functions of daratumumab in multiple myeloma | 최윤석 |
| 2014 | | Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial | 최진혁 |
| 2017 | | Adjuvant concurrent chemoradiotherapy with low-dose daily cisplatin for extrahepatic bile duct cancer | 강석윤, 김지훈, 노오규, 박래웅, 오영택, 윤덕용, 이현우, 전미선 |
| 1998 | | Alpha-fetoprotein-producing gastric cancer. | 임호영, 최진혁 |
| 2022 | | Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin | 강석윤, 김철호, 김태환, 신승수, 신유섭, 안미선, 오영택, 이현우, 장전엽, 최용원, 최진혁, 허재성 |
| 2022 | | Analysis of thromboembolic events in patients with non-small cell lung cancer who received adjuvant chemotherapy: single-center real-world data | 강석윤, 김태환, 신승수, 안미선, 이현우, 최용원, 최진혁 |
| 2022 | | Analysis of treatment outcomes according to the cycles of adjuvant chemotherapy in gastric cancer: a retrospective nationwide cohort study | 강석윤, 김태환, 안미선, 이현우, 최용원, 최진혁 |
| 1997 | | Association of hemostatic factors with peripheral vascular disease. | 김효철 |
| 2018 | | Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study | 강석윤, 이현우 |
| 2015 | | Auxiliary partial orthotopic liver transplantation as a treatment for hemophilia a: a case report. | 김봉완, 왕희정, 이현우 |
| 2014 | | B-RafV600E inhibits sodium iodide symporter expression via regulation of DNA methyltransferase 1. | 김장희, 박태준, 소의영, 이정훈, 최용원, 최용준 |
| 2011 | | Bax predicts outcome in gastric cancer patients treated with 5-fluorouracil, leucovorin, and oxaliplatin palliative chemotherapy. | 강석윤, 김장희, 박준성, 신승수, 안미선, 이광재, 이현우, 정성현, 최진혁, 한재호 |
| 2022 | | BCL2 super-expressor diffuse large B-cell lymphoma: a distinct subgroup associated with poor prognosis | 노진, 정성현, 최윤석 |
| 2022 | | Bendamustine Plus Rituximab for Mantle Cell Lymphoma: A Korean, Multicenter Retrospective Analysis | 최윤석 |
| 1997 | | Bilateral primary renal non-Hodgkin's lymphoma presenting with acute renal failure: successful treatment with systemic chemotherapy. | 최진혁 |
| 1994 | | Case report of an inhibitor patient treated with recombinant factor VIII. | 김효철 |
| 2024 | | CDK4/6 inhibitors induce breast cancer senescence with enhanced anti-tumor immunogenic properties compared with DNA-damaging agents | MUHAMMAD, IMRAN, 김영화, 박태준, 최용원, 최재호 |
| 2024 | | Cellular senescence is associated with the spatial evolution toward a higher metastatic phenotype in colorectal cancer | 김영화, 김장희, 박순상, 박태준, 이영경, 임수빈, 최용원 |
| 2014 | | Changes in osteoblastic activity in patient who received bortezomib as second line treatment for plasma cell myeloma: a prospective multicenter study | 박준성 |
| 1994 | | Changing trends in histologic types of lung cancer during the last decade (1981-1990) in Korea: a hospital-based study. | 임호영 |
| 2022 | | Characteristics and treatment patterns in older patients with locally advanced head and neck cancer (KCSG HN13-01) | 최진혁 |
| 2016 | | Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer | 강석윤 |
| 2012 | | Clinical features and outcomes of Hodgkin's lymphoma in Korea: Consortium for Improving Survival of Lymphoma (CISL) | 박준성 |
| 2014 | | Clinical outcomes and prognostic factors of empirical antifungal therapy with itraconazole in the patients with hematological malignancies: a prospective multicenter observational study in Korea. | 박준성 |
| 2019 | | Clinical Outcomes of Decitabine Treatment for Patients With Lower-Risk Myelodysplastic Syndrome on the Basis of the International Prognostic Scoring System | 정성현 |
| 2003 | | Clinical significance of bone marrow micrometastasis detected by nested rt-PCR for keratin-19 in breast cancer patients. | 김명욱, 박준성, 박희붕, 소의영, 이국종, 임현이, 정용식 |
| 2014 | | Clinical significance of cryptic chromosomal translocations detected by multiplex RT-PCR in patients with acute leukemia. | 강석윤, 박준성, 안미선, 이현우, 정성현, 조성란, 최진혁 |
| 2016 | | Clinical significance of post-treatment (18)F-fluorodeoxyglucose uptake in cervical lymph nodes in patients with diffuse large B-cell lymphoma | 안영실, 윤준기, 이수진, 이현우, 정성현 |
| 2024 | | Colon cancer: the 2023 Korean clinical practice guidelines for diagnosis and treatment | 안미선, 윤준기 |
| 2014 | | Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: randomized phase II multicenter trial. | 강석윤 |
| 2020 | | Combination versus single-agent as palliative chemotherapy for gastric cancer | 강석윤, 박준성, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁 |
| 2018 | | Comparative analyses of nilotinib versus high-dose imatinib versus sustained standard-dose imatinib in patients with chronic phase chronic myeloid leukemia following suboptimal molecular response to first-line imatinib | 박준성 |
| 1996 | | Comparison of antiproliferative effects of 1-histamine-2 receptor antagonists, cimetidine, ranitidine, and famotidine, in gastric cancer cells. | 김진홍, 김효철, 이광재, 조성원, 함기백 |
| 2022 | | Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic Alterations | 안미선 |
| 2023 | | Comprehensive Molecular Characterization of Soft Tissue Sarcoma for Prediction of Pazopanib-Based Treatment Response | 권민석 |
| 2006 | | Concurrent chemoradiotherapy in patients with nasopharyngeal cancer: prognostic significance of low expression of bax. | 강석윤, 강승희, 김철호, 김효철, 박준성, 오영택, 이현우, 장준호, 전미선, 주희재, 최진혁, 한재호 |
| 1996 | | Concurrent presentation of erythrocytic and megakaryocytic aplasia. | 김효철 |
| 2021 | | Crosstalk between HSPA5 arginylation and sequential ubiquitination leads to AKT degradation through autophagy flux | 김철호, 박준성, 정성현, 최용원 |
